Clinical Trial Update: Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS [Phase 1]

View source ↗

Summary

This Clinical Trial Update reports on a Phase 1 study evaluating the safety and immunogenicity of recombinant HIV vaccines for acquired immunodeficiency syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Acquired Immunodeficiency Syndrome | Phase 1 | Status: UNKNOWN